Very Long Term Results After Laparoscopic Retrocolic Antegastric Gastric Bypass
- Conditions
- Clinically Severe Obesity
- Registration Number
- NCT01040507
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
The main aim of this study is to analyze and report the very long-term outcomes after primary laparoscopic proximal Roux-en-Y gastric bypass surgery for clinically severe obesity.
- Detailed Description
There is lack of very-long term outcomes after bariatric surgery; A few series have been reported. However, most of them analyze medium-term outcomes. For RYGB, there are just two retrospective cohort studies reporting very long-term outcomes. Both studies have an open approach and a proximal Roux-en-Y configuration with different pouch orientation and size. MacLean´s series, with a better follow-up rate (83.4%), had a 67.6%EWL at a mean of 11.4 years; Failure rates were 20 and 35% for the morbidly obese and super obese, respectively. We will analyze our own series with a laparoscopic approach, vertically, lesser-curve base \< 10-15ml pouch and proximal Roux limb. The main end-points for our study are 1) Morbidity including status of specific biochemical markers \& Mortality, 2) Weight loss expressed as BMI or %EWL, 3) Trends in major comorbidities and 4) Assessment of Quality of Life.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 242
-
patients who met NIH criteria for recommendation of a bariatric procedure with a combination of the following characteristics
- status post primary laparoscopic proximal RYGB surgery with or without subsequent open or laparoscopic revisions or re-operations
- follow up > 10.0 years (Very long term outcome)
- patients who had a previous gastric or bariatric procedure
- patients who underwent primary laparoscopic RYGB somewhere else by other surgical group
- missing records and/or unreachable patients with scant information for analysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight loss expressed as Body Mass Index and Percentage excess weight loss throughout follow-up Comorbidity status throughout follow-up Health-related Quality of Life (HR-QoL) at last follow-up Subjective satisfaction at the last follow-up Morbidity and mortality throughout follow-up
- Secondary Outcome Measures
Name Time Method Nutritional and metabolic status throughout follow-up
Trial Locations
- Locations (1)
UCSF Fresno Center for Medical Education and Research, Department of Surgery
🇺🇸Fresno, California, United States